RxDoctor Payments Data

Lucy Rashid, NP

Nurse Practitioner · Charlotte, NCNPI 1326410770

Payments from drug & device makers

$1,835in general payments, 2019–2025

Across 17 payments — averaging $107.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$1K
  • Abiomed$262
  • Alnylam Pharmaceuticals Inc.$61
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$61
  • Kestra Medical Technology Services, Inc.$43
  • Novo Nordisk$35
  • plus $69 from 3 others

What the payments were for

  • Consulting fees$1,27569%
  • Food & beverage$52829%
  • Education$322%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,835 in reported general payments places this provider in the 85th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina

Medicare billing

Part B allowed, 2024
$15,009
Medicare patients
98
Services billed
181

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CamzyosMavacamten54$481,630
EntrestoSacubitril/Valsartan52$83,595
JardianceEmpagliflozin40$35,889
EliquisApixaban31$26,717
FarxigaDapagliflozin Propanediol13$18,453
Torsemide49$1,218
Potassium Chloride31$946
Metoprolol Succinate54$721
Spironolactone63$497
Amiodarone Hcl15$326
Atorvastatin Calcium19$292
Carvedilol48$271
Furosemide45$179
Diltiazem 24hr Er (Cd)Diltiazem Hcl13$165
Losartan Potassium25$137

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
E.r. Squibb & Sons, L.L.C.Camzyos$1,305$481,63054 claims
NovartisEntresto$24$83,59552 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,393 nurse practitioner providers in North Carolina.

Other nurse practitioner in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →